Remedium Lifecare Peer Comparison

BSE: 539561

₹0.27

₹0.00 (0.00%)

As on 21-Sep-2026IST

Market cap

₹24 Cr

Revenue (TTM)

₹147 Cr

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	24	20,956	20,944	17,950	18,477
Revenue (₹ Cr)	147	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	-2.17	678.07	273.51	666.92	735.15
Net Margin (%)	-1.34	28.10	16.19	20.60	26.88
RoE (%)	-3.24	19.73	11.15	18.75	19.16
Price to Earnings	--	31.50	70.44	27.88	25.13
Price-To-Book	0.26	5.71	7.80	4.45	4.19

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	405.25	1,937.47	1,286.43	2,893.64	2,281.35
Total Income	416.05	2,033.90	1,322.88	2,912.00	2,453.60
Total Expenditure	403.99	1,290.54	980.18	1,876.44	1,541.03
EBITDA	1.26	646.93	306.25	1,017.20	740.32
Depreciation	0.04	65.96	112.99	315.46	60.79
EBIT	1.22	580.97	193.26	701.74	679.53
Interest	7.64	0.61	75.53	231.29	8.50
Other Income	10.80	96.43	36.45	18.36	172.25
Exceptional Items	--	--	-30.58	--	172.81
Profit before Tax	4.38	676.78	122.33	488.87	1,016.09
Provision for Tax	2.26	135.69	44.04	114.20	248.49
Profit after Tax	2.13	541.09	78.29	374.67	767.60

Liabilities (₹ Cr)

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	43.89	2,850.49	2,362.70	2,854.36	4,217.41
Minority Interest	--	35.90	1.04	417.40	--
Non-Current Liabilities	-0.04	13.24	259.78	2,100.97	54.89
Current Liabilities	1,676.46	305.99	674.19	1,492.79	569.51
Total Liabilities	1,720.35	3,207.85	3,310.68	6,865.52	4,911.11

Assets (₹ Cr)

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	0.01	1,071.67	2,313.20	5,531.13	1,328.96
Current Assets	1,720.31	2,133.95	984.51	1,334.39	3,512.85
Total Assets	1,720.35	3,207.85	3,310.68	6,865.52	4,911.11
Total Debt*	1,141.39	0.55	586.37	2,421.66	2.50
Net Current Assets	43.85	1,827.96	310.32	-158.40	2,943.34
Contingent Liabilities	--	0.64	76.22	51.96	363.79

Cashflow (₹ Cr)

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	-1,134.81	432.37	132.27	1,065.01	659.75
Cash Flow from Investing Activities	0.13	-334.73	-199.13	-79.97	-71.34
Cash from Financing Activities	1,136.10	-38.32	62.65	-881.32	-205.34
Net Cash Inflow / Outflow	1.43	59.32	-4.21	103.72	383.07

Ratios

Profitability Ratios

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	1.01	26.22	6.95	13.59	26.21
ROE (%)	4.85	21.72	3.75	13.81	19.65
ROA (%)	0.12	18.37	2.45	5.48	17.03
EBIT Margin (%)	2.98	38.37	26.64	35.79	40.00
Net Margin (%)	0.51	26.60	5.92	12.87	31.28
Cash Profit Margin (%)	0.54	31.33	14.87	23.21	34.70

Growth Ratios

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	0.00	14.37	11.71	44.02	4.02
EBIT Growth (%)	591.52	20.21	35.64	48.22	11.86
Net Profit Growth (%)	0.00	17.27	145.00	-5.65	39.23
EPS Growth (%)	0.00	17.25	118.00	-10.39	39.23
Book Value Growth (%)	0.00	23.77	30.63	10.19	17.30

Valuation Ratios

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	24.06	28.38	41.41	54.83	23.86
Price / Book Value	1.67	5.52	2.74	6.78	4.34
Dividend Yield (%)	0.00	0.30	0.15	0.52	4.12
EV/EBITDA	100.58	19.78	20.55	20.75	17.01
Market Cap (₹ Cr)	73.39	15,219.80	6,484.12	19,292.77	18,318.10

Solvency Ratios

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	26.01	0.00	0.25	0.85	0.00
Short term debt to equity ratio	26.01	0.00	0.13	0.14	0.00
Current Ratio	1.03	6.97	1.46	0.89	6.17
Quick Ratio	0.87	5.88	0.94	0.67	5.33
Interest Coverage	1.57	1,110.48	2.62	3.11	120.54

Operating Efficiency Ratios

	Remedium Lifecare	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	190.41	32.65	34.26	15.85	8.46
Asset Turnover	0.24	0.66	0.40	0.43	0.53
Receivable days	694.98	110.70	118.15	54.06	29.10
Inventory Days	242.62	65.86	98.29	32.16	69.53
Payable days	459.27	105.88	128.16	140.91	76.77
Cash Conversion Cycle	478.33	70.68	88.28	-54.69	21.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.